Details of the Drug Formulations

General Information of Drug (ID: DM3Q1SM)

Drug Name
obeticholic acid Drug Info
Synonyms INT747; INT-747; 6-ethylchenodeoxycholic acid; 6-ECDCA; OCA; 6-Et CDCA
Indication
Disease Entry ICD 11 Status REF
Primary biliary cholangitis DB96.1 Approved [1]
Insomnia 7A00-7A0Z Clinical trial [2]
Cross-matching ID
PubChem CID
447715
ChEBI ID
CHEBI:43602
CAS Number
459789-99-2
TTD ID
D0M4WA
INTEDE ID
DR1183
ACDINA ID
D00482

Full List of Drug Formulations Containing This Drug

Obeticholic acid 10 mg tablet
Company Formulation ID FDA Description
Intercept Pharmaceuticals F15558 Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 3350; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Obeticholic acid 5 mg tablet
Company Formulation ID FDA Description
Intercept Pharmaceuticals F15559 Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 3350; Microcrystalline cellulose; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
2 Nuclear receptors and lipid physiology: opening the X-files. Science. 2001 Nov 30;294(5548):1866-70.